A PA’s Guide to Brain Health and Alzheimer’s Disease Detection
Jordan Mast, MMS, PA-C
In this series, Jordan Mast, a PA at the Colorado Neurological Clinic in Denver, offers practical guidance to support earlier identification of cognitive impairment and Alzheimer’s disease.
Across four videos, PA Mast reviews common factors that can delay diagnosis, outlines when blood-based biomarker testing may be appropriate, and explains how to interpret screening and diagnostic data within the context of the whole patient.
The series also highlights evidence-informed strategies PAs can use to counsel patients on lifelong brain health, including cardiovascular and metabolic risk management, physical activity, nutrition, cognitive and social engagement, sleep, mental health, and medication review.
Video 1: Avoiding Delays in Alzheimer’s Disease Diagnosis
Identify patient and screening factors that can delay detection of mild cognitive impairment and apply strategies that support earlier Alzheimer’s disease diagnosis.
Video 2: How Can Alzheimer’s Disease Be Detected With Blood-based Biomarkers?
Understand who should receive blood-based biomarker testing, what amyloid beta and p-tau markers indicate, and how BBM results can help identify patients for further Alzheimer’s disease evaluation.
Video 3: Cognitive Evaluation for Alzheimer’s – What Not to Miss
Learn how to integrate screening results, patient history, labs, imaging, biomarkers, and clinical judgment to avoid missing Alzheimer’s disease and other contributors to cognitive decline.
Video 4: Can Dementia Be Prevented by Promoting Brain Health?
Apply evidence-informed strategies to promote brain health and reduce dementia risk, including cardiovascular and metabolic risk management, physical activity, nutrition, cognitive and social engagement, sleep, mental health support, and medication review.
Supported by
